What types of marketing or claims should CBD companies (or other companies that sell herbal products) avoid, so they don’t get a warning letter from the FDA?
Simply put, companies should avoid the use of the words COVID-19, coronavirus, Wuhan virus, and corresponding language. As a general rule, anything a drug is indicated for is most likely a claim (e.g. aspirin indicated for fever).
Hashtags are also claims. Using #coronavirus, for example, on an otherwise compliant marketing campaign can alert the FDA and give the appearance you are insinuating your product is useful for the coronavirus.
The recent warning letters cited companies not just for making claims, but also for insinuating them. [...]
We had the opportunity to visit with industry expert Bill Brill and get his take on where the industry challenges and opportunities are.
If you want to skip forward to specific questions use this guide:
Questions and Answers:
Bill's Background | Minute 1:20
Industrial Hemp Genetics? | Minute 3:50
Working with Hemp Farmers? | Minute 7:00
Oil Extraction? | Minute 11:18
Other ingredients in hemp plant and pharma? | Minute 14:20
The Need for Information & Education? | Minute 18:00
Where's the Finished Goods Marketing Going? | Minute 21:45
Future of the Industrial Hemp Industry? | Minute 29:00
Where can you find Bill Brill? | Minute 33:20 [...]
Hemp production has been classified as “essential” by the federal government during the coronavirus pandemic. But the classification doesn’t extend to retailers selling hemp and CBD — and some retailers told to shut down during the coronavirus response are asking authorities to reconsider and designate them “essential” businesses. They point out that many states classify medical … [...]
Several Colorado CBD companies are offering free products during the coronavirus pandemic, giving CBD oils, capsules, gels and even hand sanitizer to customers, health-care workers, people who've been laid off and others facing hard times financially.
Not that the owners of those companies are in much better shape.
Chris Bedrosian, founder of Lakewood hemp and CBD shop Flora's Mercantile & Hemp Emporium, says that she has about eighty bottles of CBD tincture that represented the profit from her latest batch. Although she can still sell products online, business has slowed significantly since her shop was forced to temporarily close under a statewide stay-at-home order from Governor Jared Polis. Even so, instead of selling her bottles of 2,000-milligram CBD tincture, she wants to donate them to people affected by the coronavirus.
"I can't just sit here and do nothing, but unfortunately, that's all I can do," Bedrosian says. "I'm not saying CBD will save them, but introducing CBD to your [...]
NOTE: this is a "must subscribe" publication if you have real interest in Industrial Hemp.
Supporting legal hemp cultivators with: industry trend analysis, business strategy, expert cultivation advice, extraction, marketing, financial topics, and legal issues.
HG’s mission is to support legal hemp cultivators by providing actionable intelligence in all aspects of the business—from regulatory news to analysis of industry trends and business strategy, as well as expert advice on cultivation, extraction, marketing, financial topics, legal issues and more.
HG focuses strictly on the business of legal hemp and aims to provide timely information—through its website, e-newsletter, print magazine and annual Cannabis Conference—to help the reader make timely, informed decisions to help them run their hemp businesses more efficiently and more profitably.
The first issue of Hemp Grower will be published and distributed to subscribers in late 2019. [...]
The new hemp industry is attracting some powerhouse players in agriculture, and Hemp Industry Daily went behind the scenes to see how one of the most intriguing partnerships is going.
The operation planted about 5 million high-yield CBD hemp clones on more than 1,800 acres of outdoor fields in central Kentucky, all within 15 miles of the greenhouse.
In January, AgTech Scientific will roll out CBD formulations for the food and beverage industry and its own proprietary brands. Currently the company is using a 30,000-square-foot extraction facility, which it plans to close upon completion of the first phase of a new 50,000-square-foot facility by the end of 2019. [...]
By Andrew Kelly.
Can’t happen quick enough in my opinion. In the long run, this “pop” won’t deplete the market, but rather expand it. CBD products will be cheaper and more accessible to lower income families and people who need these products in their everyday lives.
It should also spark initiative. All that biomass going to waste, all the stalk being plowed back into the fields, all the fiber being lost.
This is probably the best thing to happen to the hemp business in the last decade. Not only will it free the other 160 cannabinoids in the plant as producers seek to create products with their own “uniqueness.”
It will also bolster the innovators who have been taking a holistic view of the plant all along and are making exciting developments in everything from farming and processing technology to applications from carbons and hemp-fiber based plastics.
The hemp seed’s potential in food is massive.
Read the full articles... [...]